Ocular Therapeutix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell OCUL and other ETFs, options, and stocks.About OCUL
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC.
CEOPravin U. Dugel
CEOPravin U. Dugel
Employees274
Employees274
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded2006
Founded2006
Employees274
Employees274
OCUL Key Statistics
Market cap2.12B
Market cap2.12B
Price-Earnings ratio-9.56
Price-Earnings ratio-9.56
Dividend yield—
Dividend yield—
Average volume2.24M
Average volume2.24M
High today$12.37
High today$12.37
Low today$11.99
Low today$11.99
Open price$12.37
Open price$12.37
Volume1.98M
Volume1.98M
52 Week high$12.65
52 Week high$12.65
52 Week low$5.79
52 Week low$5.79
OCUL News
Seeking Alpha 6d
Ocular Therapeutix GAAP EPS of -$0.39 misses by $0.04, revenue of $13.5M beats by $0.38MEarnings News Ocular Therapeutix GAAP EPS of -$0.39 misses by $0.04, revenue of $13.5M beats by $0.38M Aug. 05, 2025 7:16 AM ET Ocular Therapeutix, Inc. (OCUL)...
Analyst ratings
100%
of 12 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own OCUL. This list is generated using Robinhood data, and it’s not a recommendation.